By staff writers

November 1, 2012 -- Radiation oncology firm Accuray has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new CyberKnife M6 series.

The new CyberKnife M6 FIM and FM systems feature the company's InCise multileaf collimator, which combines beam shaping with nonisocentric, noncoplanar delivery to enhance clinical capabilities and expand the number of patients eligible for treatment.

The new InCise multileaf collimator was designed specifically for stereotactic radiosurgery and stereotactic body radiation therapy, the company said.

Copyright © 2012

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking